» Articles » PMID: 21412230

A Fresh Look at the Mechanism of Isoniazid-induced Hepatotoxicity

Overview
Publisher Wiley
Specialty Pharmacology
Date 2011 Mar 18
PMID 21412230
Citations 56
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.

Sekaggya-Wiltshire C, Mbabazi I, Nabisere R, Alinaitwe L, Otaalo B, Aber F BMJ Open. 2024; 14(12):e088389.

PMID: 39740953 PMC: 11749192. DOI: 10.1136/bmjopen-2024-088389.


Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Sankar J, Chauhan A, Singh R, Mahajan D Front Pharmacol. 2024; 15:1441147.

PMID: 39364056 PMC: 11447295. DOI: 10.3389/fphar.2024.1441147.


Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis.

Thomas L, Raju A, Mallayasamy S, Rao M Eur J Drug Metab Pharmacokinet. 2024; 49(5):541-557.

PMID: 39153028 PMC: 11365851. DOI: 10.1007/s13318-024-00910-7.


Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol.

Sekaggya-Wiltshire C, Mbabazi I, Nabisere-Arinaitwe R, Banturaki G, Alinaitwe L, Otalo B medRxiv. 2024; .

PMID: 38853861 PMC: 11160854. DOI: 10.1101/2024.06.01.24308310.


Folic acid protects against isoniazid-induced liver injury via the mA RNA methylation of cytochrome P450 2E1 in mice.

Jiang L, Ni Y, Zhao C, Gao D, Gai X, Xiong K Front Nutr. 2024; 11:1389684.

PMID: 38798770 PMC: 11116731. DOI: 10.3389/fnut.2024.1389684.